molecular function |
| GO:0042056 | | chemoattractant activity | | Providing the environmental signal that initiates the directed movement of a motile cell or organism towards a higher concentration of that signal. |
| GO:0008083 | | growth factor activity | | The function that stimulates a cell to grow or proliferate. Most growth factors have other actions besides the induction of cell growth or proliferation. |
| GO:0042802 | | identical protein binding | | Interacting selectively and non-covalently with an identical protein or proteins. |
| GO:0005515 | | protein binding | | Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
| GO:0046982 | | protein heterodimerization activity | | Interacting selectively and non-covalently with a nonidentical protein to form a heterodimer. |
| GO:0004252 | | serine-type endopeptidase activity | | Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain by a catalytic mechanism that involves a catalytic triad consisting of a serine nucleophile that is activated by a proton relay involving an acidic residue (e.g. aspartate or glutamate) and a basic residue (usually histidine). |
biological process |
| GO:0000187 | | activation of MAPK activity | | The initiation of the activity of the inactive enzyme MAP kinase (MAPK). |
| GO:0031100 | | animal organ regeneration | | The regrowth of a lost or destroyed animal organ. |
| GO:0060326 | | cell chemotaxis | | The directed movement of a motile cell guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis). |
| GO:0000902 | | cell morphogenesis | | The developmental process in which the size or shape of a cell is generated and organized. |
| GO:0008283 | | cell proliferation | | The multiplication or reproduction of cells, resulting in the expansion of a cell population. |
| GO:0035729 | | cellular response to hepatocyte growth factor stimulus | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hepatocyte growth factor stimulus. |
| GO:0001837 | | epithelial to mesenchymal transition | | A transition where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell. |
| GO:0048012 | | hepatocyte growth factor receptor signaling pathway | | The series of molecular signals generated as a consequence of the hepatocyte growth factor receptor binding to one of its physiological ligands. |
| GO:0030212 | | hyaluronan metabolic process | | The chemical reactions and pathways involving hyaluronan, the naturally occurring anionic form of hyaluronic acid, any member of a group of glycosaminoglycans, the repeat units of which consist of beta-1,4 linked D-glucuronyl-beta-(1,3)-N-acetyl-D-glucosamine. |
| GO:0001889 | | liver development | | The process whose specific outcome is the progression of the liver over time, from its formation to the mature structure. The liver is an exocrine gland which secretes bile and functions in metabolism of protein and carbohydrate and fat, synthesizes substances involved in the clotting of the blood, synthesizes vitamin A, detoxifies poisonous substances, stores glycogen, and breaks down worn-out erythrocytes. |
| GO:0051450 | | myoblast proliferation | | The multiplication or reproduction of myoblasts, resulting in the expansion of a myoblast cell population. A myoblast is a mononucleate cell type that, by fusion with other myoblasts, gives rise to the myotubes that eventually develop into skeletal muscle fibers. |
| GO:0043066 | | negative regulation of apoptotic process | | Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process. |
| GO:0010507 | | negative regulation of autophagy | | Any process that stops, prevents, or reduces the frequency, rate or extent of autophagy. Autophagy is the process in which cells digest parts of their own cytoplasm. |
| GO:0043154 | | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process | | Any process that stops, prevents, or reduces the frequency, rate or extent of a cysteine-type endopeptidase activity involved in the apoptotic process. |
| GO:1902042 | | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors | | Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway via death domain receptors. |
| GO:1901299 | | negative regulation of hydrogen peroxide-mediated programmed cell death | | Any process that stops, prevents or reduces the frequency, rate or extent of hydrogen peroxide-mediated programmed cell death. |
| GO:0050728 | | negative regulation of inflammatory response | | Any process that stops, prevents, or reduces the frequency, rate or extent of the inflammatory response. |
| GO:0032715 | | negative regulation of interleukin-6 production | | Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-6 production. |
| GO:0033137 | | negative regulation of peptidyl-serine phosphorylation | | Any process that stops, prevents, or reduces the frequency, rate or extent of the phosphorylation of peptidyl-serine. |
| GO:0090201 | | negative regulation of release of cytochrome c from mitochondria | | Any process that decreases the rate, frequency or extent of release of cytochrome c from mitochondria, the process in which cytochrome c is enabled to move from the mitochondrial intermembrane space into the cytosol, which is an early step in apoptosis and leads to caspase activation. |
| GO:0002576 | | platelet degranulation | | The regulated exocytosis of secretory granules containing preformed mediators such as histamine and serotonin by a platelet. |
| GO:0050918 | | positive chemotaxis | | The directed movement of a motile cell or organism towards a higher concentration of a chemical. |
| GO:2000573 | | positive regulation of DNA biosynthetic process | | Any process that activates or increases the frequency, rate or extent of DNA biosynthetic process. |
| GO:0045766 | | positive regulation of angiogenesis | | Any process that activates or increases angiogenesis. |
| GO:0030335 | | positive regulation of cell migration | | Any process that activates or increases the frequency, rate or extent of cell migration. |
| GO:0008284 | | positive regulation of cell proliferation | | Any process that activates or increases the rate or extent of cell proliferation. |
| GO:0032733 | | positive regulation of interleukin-10 production | | Any process that activates or increases the frequency, rate, or extent of interleukin-10 production. |
| GO:0031643 | | positive regulation of myelination | | Any process that activates or increases the frequency, rate or extent of the formation of a myelin sheath around nerve axons. |
| GO:0070572 | | positive regulation of neuron projection regeneration | | Any process that activates or increases the frequency, rate or extent of neuron projection regeneration, the regrowth of neuronal processes such as axons or dendrites following their loss or damage. |
| GO:0045669 | | positive regulation of osteoblast differentiation | | Any process that activates or increases the frequency, rate or extent of osteoblast differentiation. |
| GO:0050731 | | positive regulation of peptidyl-tyrosine phosphorylation | | Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-tyrosine. |
| GO:0014068 | | positive regulation of phosphatidylinositol 3-kinase signaling | | Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the phosphatidylinositol 3-kinase cascade. |
| GO:0045944 | | positive regulation of transcription from RNA polymerase II promoter | | Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter. |
| GO:0006508 | | proteolysis | | The hydrolysis of proteins into smaller polypeptides and/or amino acids by cleavage of their peptide bonds. |
| GO:0060665 | | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling | | Any process that modulates the rate, frequency, or extent of branching involved in salivary gland morphogenesis as a result of signals being generated by the mesenchyme and received and interpreted by the salivary gland epithelium. |
| GO:1900744 | | regulation of p38MAPK cascade | | Any process that modulates the frequency, rate or extent of p38MAPK cascade. |
| GO:1902947 | | regulation of tau-protein kinase activity | | Any process that modulates the frequency, rate or extent of tau-protein kinase activity. |
cellular component |
| GO:0005576 | | extracellular region | | The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite. |
| GO:0005615 | | extracellular space | | That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid. |
| GO:0016020 | | membrane | | A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it. |
| GO:0031093 | | platelet alpha granule lumen | | The volume enclosed by the membrane of the platelet alpha granule. |